copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Chiesi USA Chiesi USA is committed to developing and commercializing products that meet the needs of healthcare providers and their patients We deliver our products and associated services to improve the lives of patients
Products - Chiesi USA Chiesi USA is committed to developing and commercializing products that meet the needs of healthcare providers and their patients We deliver our products and associated services to improve the treatment of patients
About us - Chiesi USA Chiesi is a sustainable pharmaceutical company committed to generating economic value in a way that also benefits society by addressing its needs and challenges, thus connecting the company’s success with social progress We are dedicated to people, patients, and the planet
Pipeline - Chiesi USA Chiesi USA’s development pipeline consists of new molecular entities and continues to make significant progress Programs include innovative anti-inflammatory, bronchodilator, and antifibrotic molecules
CHIESI USA, Inc. Chiesi Global Rare Diseases is a business unit of the Chiesi Group established in February 2020 and focused on research and development of treatments for rare and ultra-rare disorders
CHIESI USA Chiesi USA was established in 2014 with the acquisition of Cornerstone Therapeutics Inc , as the culmination of a strong strategic alliance first formed in 2009 The organizations shared a focus on their people and a desire to address unmet medical needs in the specialty setting
Current Openings - Chiesi USA We’re so glad you’re considering joining Chiesi USA, Inc (Chiesi [key-ay-zee]) At Chiesi, we’re proud to be a Public Benefit Corporation and a certified B Corp, following high standards for social and environmental impact
Chiesi Group delivers on transformational strategy with FY2024 Parma (Italy), April 16 th, 2025 – Chiesi, an international research-oriented biopharmaceutical group headquartered in Parma, Italy, with commercial affiliates in 31 countries, closed 2024 with strong financial results, reaffirming its trajectory of sustainable, long-term growth with a strong commitment to fostering R D and innovation
News - Chiesi USA Chiesi Global Rare Diseases Recognizes Fabry Disease Awareness Month and Launches “Fabry Focus on Health” Educational Series to Support Patients and Caregivers During COVID-19 Pandemic